A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer.
Saved in:
| Title: | A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer. |
|---|---|
| Authors: | Volders PJ; Laboratory for Molecular Diagnostics, Jessa Hospital, Hasselt, Belgium.; Faculty of Medicine and Life Sciences, LCRC, University of Hasselt, Hasselt, Belgium.; Department of Biomolecular Medicine, Ghent University, Gent, Belgium., Aftimos P; Clinical Trials Conduct Unit, Institut Jules Bordet-Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium., Dedeurwaerdere F; Department of Pathology, AZ Delta Hospital, Roeselare, Belgium., Martens G; Department of Laboratory Medicine, AZ Delta Hospital, Roeselare, Belgium., Canon JL; Department of Medical Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium., Beniuga G; Institut de Pathologie et de Génétique, Charleroi, Belgium., Froyen G; Laboratory for Molecular Diagnostics, Jessa Hospital, Hasselt, Belgium.; Faculty of Medicine and Life Sciences, LCRC, University of Hasselt, Hasselt, Belgium., Van Huysse J; Department of Pathology, AZ Sint-Jan Brugge, Bruges, Belgium., De Pauw R; Department of Pulmonology, AZ Sint-Jan Brugge, Bruges, Belgium., Prenen H; Department of Oncology, Antwerp University Hospital, Edegem, Belgium.; Center for Oncological research, University of Antwerp, Wilrijk, Belgium., Lambin S; Department of Pathology, University Hospital Antwerp, Edegem, Belgium., Decoster L; Department of Medical Oncology, University Hospital Brussels, Brussels, Belgium.; Laboratory for Medical and Molecular Oncology, Vrije Universiteit, Brussels, Belgium., Vaeyens F; Centre for Medical Genetics, University Hospital Brussels, Brussels, Belgium., Rottey S; Department of Medical Oncology, Ghent University, Ghent, Belgium., Van Dam PJ; CellCarta, Antwerp, Belgium., Decoster L; Department of Pulmonology, AZ Turnhout, Turnhout, Belgium., Rutten A; Department of Medical Oncology, ZAS hospitals, Antwerp, Belgium., Schreuer M; Department of Medical Oncology, ASZ Aalst, Aalst, Belgium., Loontiens S; Department of Biomolecular Medicine, Ghent University, Gent, Belgium.; Molecular Diagnostics, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent University, Ghent, Belgium., Van der Meulen J; Department of Biomolecular Medicine, Ghent University, Gent, Belgium.; Molecular Diagnostics, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent University, Ghent, Belgium., Mebis J; Faculty of Medicine and Life Sciences, LCRC, University of Hasselt, Hasselt, Belgium.; Department of Medical Oncology, Jessa Hospital, Hasselt, Belgium., Cuppens K; Faculty of Medicine and Life Sciences, LCRC, University of Hasselt, Hasselt, Belgium.; Department of Pulmonology and Thoracic Oncology, Jessa Hospital, Hasselt, Belgium., Tejpar S; Digestive Oncology, University Hospitals KU Leuven, Leuven, Belgium., Vanden Bempt I; Department of Human Genetics, University Hospitals KU Leuven, Leuven, Belgium., De Grève J; Laboratory for Medical and Molecular Oncology, Vrije Universiteit, Brussels, Belgium.; Centre for Medical Genetics, University Hospital Brussels, Brussels, Belgium., Schröder D; Department of Medical Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium., van Marcke C; Institute for Experimental and Clinical Research, UCLouvain, Brussels, Belgium.; Department of Medical Oncology, Institut Roi Albert II, Cliniques universitaires Saint-Luc, Brussels, Belgium., Van Den Bulcke M; Sciensano, Brussels, Belgium., de Azambuja E; Institut Jules Bordet, Hôpital Universitaire de Bruxelles and l'Université Libre de Bruxelles, Brussels, Belgium., Punie K; Department of Medical Oncology, ZAS hospitals, Antwerp, Belgium., Maes B; Laboratory for Molecular Diagnostics, Jessa Hospital, Hasselt, Belgium. Brigitte.maes@jessazh.be.; Faculty of Medicine and Life Sciences, LCRC, University of Hasselt, Hasselt, Belgium. Brigitte.maes@jessazh.be. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2025 Mar 10; Vol. 9 (1), pp. 66. Date of Electronic Publication: 2025 Mar 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2397-768X |
|---|---|
| DOI: | 10.1038/s41698-025-00858-0 |
